FindMyKOL
Clinical trialNCT05454566WithdrawnPhase 1/2Interventional

A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis.

NCT05454566 is a phase 1/2 interventional trial sponsored by ICM Co. Ltd.. As of 21 Nov 2026, it was withdrawn. It studies Osteoarthritis, Knee. The registry lists an enrollment of 0 participants. The registry lists a start date of 15 Nov 2026 and a primary completion date of 15 May 2027.

SponsorICM Co. Ltd.Enrollment0Osteoarthritis, Knee
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT05454566
FieldValue
Registry IDNCT05454566
StatusWithdrawn
PhasePhase 1/2
Study typeInterventional trial
Lead sponsorICM Co. Ltd.
Enrollment0
ConditionsOsteoarthritis, Knee
Start15 Nov 2026
Primary completion15 May 2027
Study completion15 Nov 2028
Last update posted8 Sept 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine the safety, tolerability, and activity of ICM-203, a recombinant adeno-associated viral (AAV) vector that expresses a therapeutic gene that promotes cartilage formation, reduces joint inflammation and pain, as well as improves joint physical function, by injecting escalating doses of ICM-203 into the knee of subjects with mild to moderate knee osteoarthritis (OA). Approximately 6 to 18 subjects will be enrolled into 3 successive dose-escalating groups in a 3+3 study design, whereby 3 study subjects in each group will be dosed sequentially with ICM-203 and 3 additional subjects will be dosed at the same dose level if a dose limiting toxicity (DLT) occurs in any of the first 3 subjects.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT05454566

Each answer restates registry values shown on this page.

What is NCT05454566?

NCT05454566 is a phase 1/2 interventional trial sponsored by ICM Co. Ltd.. It studies Osteoarthritis, Knee.

Who leads NCT05454566?

The registry names Alison Heald, MD (study director, ICM Co. Ltd.) as the overall official.

When did NCT05454566 end?

The registry lists a primary completion date of 15 May 2027 and a study completion date of 15 Nov 2028. The sponsor last updated the record on 8 Sept 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.